# Study of Single Doses of SBT115301 in Healthy Participants

> **NCT05388981** · PHASE1 · COMPLETED · sponsor: **Sonoma Biotherapeutics, Inc.** · enrollment: 40 (actual)

## Conditions studied

- Safety

## Interventions

- **BIOLOGICAL:** SBT115301
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT05388981
- **Lead sponsor:** Sonoma Biotherapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-25
- **Primary completion:** 2024-01-03
- **Final completion:** 2024-01-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05388981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05388981, "Study of Single Doses of SBT115301 in Healthy Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05388981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*